Evidence map›Paper›PMID 31653155›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2019

Assessment of the Antitumor Potentiality of Newly Designed Steroid Derivatives: Pre-Clinical Study.

Dina S El-Kady, Naglaa A Ali, Alaa H Sayed, Mervat M Abdelhaliem, Gamal A Elmegeed, Hanaa H Ahmed

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Modification of B-Nor Steroids Mediated by Filamentous FungusInternational journal of molecular sciences · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dina S El-KadyDepartment of Hormones, Medical Research Division, National Research Centre, Dokki, Giza, Egypt.
Naglaa A AliDepartment of Hormones, Medical Research Division, National Research Centre, Dokki, Giza, Egypt.
Alaa H SayedDepartment of Hormones, Medical Research Division, National Research Centre, Dokki, Giza, Egypt.
Mervat M AbdelhaliemDepartment of Hormones, Medical Research Division, National Research Centre, Dokki, Giza, Egypt.
Gamal A ElmegeedDepartment of Hormones, Medical Research Division, National Research Centre, Dokki, Giza, Egypt.
Hanaa H AhmedDepartment of Hormones, Medical Research Division, National Research Centre, Dokki, Giza, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is recognized as one of the most prevalent contributors to mortality in several nations and it remains one of the common health issues globally. In particular, hepatocellular carcinoma (HCC) has become a public health problem along with the increase of hepatitis B (HBV) and hepatitis C (HCV) virus infections. Based on this fact, our study goaled to synthesize newly hybrid drugs containing heterocyclic rings incorporated to steroid moiety and to examine the potential antitumor activity of the newly designed heterosteroid derivatives against HCC induced in animal model. Several heterocyclic steroids were synthesized 2-7 and confirmed via the analytical and spectral data (IR, 1H NMR13C NMR and Mass spectroscopy). Compounds 3, 4, and 5 were chosen to be investigated as anticancer agents in HCC rat model by means of validated biomarkers (alfa -fetoprotein, endoglin, lipocali-2 and heat shock protein-70). Following administration of compounds 3, 4 or 5, availability of the active tumor marker molecules was significantly dropped and a substantial decrease of the angiogenic and inflammatory mediators was also evident. These findings were supported by the histological examination of liver tissue. Taken together, this study indicates the potential anticancer activity of the newly synthesized heterosteroid derivatives against HCC in vivo. The antitumor activity of these compounds was likely attributable to modulating some signal transduction pathways involved in tumorigenesis, angiogenesis and inflammation.

Indexed as

AnimalsAntineoplastic AgentsCarcinoma, HepatocellularDrugs, InvestigationalInflammationLiver Neoplasms, ExperimentalMaleNeovascularization, PathologicRatsRats, WistarSteroidsAntineoplastic AgentsDrugs, InvestigationalSteroidsAngiogenesisHepatocellular carcinomaHeterosteroidsInflammationTumor markers

Identifiers

PMID31653155
PMCPMC6982653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.